Bachert C, Han JK, Wagenmann M, et al. EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: definitions and management. J Allergy Clin Immunol. 2021;147:29–36. https://doi.org/10.1016/j.jaci.2020.11.013.

Article  CAS  PubMed  Google Scholar 

Settipane GA, Chafee FH. Nasal polyps in asthma and rhinitis. A review of 6,037 patients. J Allergy Clin Immunol. 1977;59:17–21. https://doi.org/10.1016/0091-6749(77)90171-3.

Article  CAS  PubMed  Google Scholar 

Hedman J, Kaprio J, Poussa T, Nieminen MM. Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol. 1999;28:717–22. https://doi.org/10.1093/ije/28.4.717.

Article  CAS  PubMed  Google Scholar 

Sanchez-Collado I, Mora T, Munoz-Cano R, et al. Prevalence of chronic rhinosinusitis with nasal polyps in Catalonia (Spain): a retrospective, large-scale population-based study. Rhin. 2022;0:0–0. https://doi.org/10.4193/Rhin21.364.

Article  Google Scholar 

Mullol J, Sastre J, Domínguez-Ortega J, et al. Prevalence of chronic rhinosinusitis without/with nasal polyps according to severity in Spain. Rhin. 2024;0:0–0. https://doi.org/10.4193/Rhin23.341.

Article  Google Scholar 

Gliklich RE, Metson R. The health impact of chronic sinusitis in patients seeking otolaryngologic care. Otolaryngol Head Neck Surg. 1995;113:104–9. https://doi.org/10.1016/S0194-59989570152-4.

Article  CAS  PubMed  Google Scholar 

Alobid I, Benítez P, Bernal-Sprekelsen M, et al. Nasal polyposis and its impact on quality of life: comparison between the effects of medical and surgical treatments. Allergy. 2005;60:452–8. https://doi.org/10.1111/j.1398-9995.2005.00725.x.

Article  CAS  PubMed  Google Scholar 

Sahlstrand-Johnson P, Ohlsson B, Von Buchwald C, et al. A multi-centre study on quality of life and absenteeism in patients with CRS referred for endoscopic surgery. Rhinology. 2011;49:420–8. https://doi.org/10.4193/Rhino11.101.

Article  CAS  PubMed  Google Scholar 

DeConde AS, Mace JC, Levy JM, et al. Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis. Laryngoscope. 2017;127:550–5. https://doi.org/10.1002/lary.26391.

Article  PubMed  Google Scholar 

Rosati D, Rosato C, Pagliuca G, et al. Predictive markers of long-term recurrence in chronic rhinosinusitis with nasal polyps. Am J Otolaryngol. 2020;41. https://doi.org/10.1016/j.amjoto.2019.102286.

Article  CAS  PubMed  Google Scholar 

Arancibia C, Langdon C, Mullol J, Alobid I. Twelve-year long-term postoperative outcomes in patients with chronic rhinosinusitis with nasal polyps. Rhinology. 2022;60:261–9. https://doi.org/10.4193/Rhin21.148.

Article  CAS  PubMed  Google Scholar 

Tomassen P, Vandeplas G, Van Zele T, et al. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. J Allergy Clin Immunol. 2016;137:1449–e14564. https://doi.org/10.1016/j.jaci.2015.12.1324.

Article  CAS  PubMed  Google Scholar 

Chaaban MR, Walsh EM, Woodworth BA. Epidemiology and differential diagnosis of nasal polyps. Am J Rhinol Allergy. 2013;27:473–8. https://doi.org/10.2500/ajra.2013.27.3981.

Article  PubMed  PubMed Central  Google Scholar 

Bachert C, Zhang N, Hellings PW, Bousquet J. Endotype-driven care pathways in patients with chronic rhinosinusitis. J Allergy Clin Immunol. 2018;141:1543–51. https://doi.org/10.1016/j.jaci.2018.03.004.

Article  PubMed  Google Scholar 

Shirley M. Dupilumab: first global approval. Drugs. 2017;77:1115–21. https://doi.org/10.1007/s40265-017-0768-3.

Article  CAS  PubMed  Google Scholar 

Wu Q, Zhang Y, Kong W, et al. Which is the best biologic for nasal polyps: dupilumab, omalizumab, or Mepolizumab? A network meta-analysis. Int Arch Allergy Immunol. 2022;183:279–88. https://doi.org/10.1159/000519228.

Article  CAS  PubMed  Google Scholar 

Boechat JL, Silva D, Sousa-Pinto B, Delgado L. Comparing biologicals for severe chronic rhinosinusitis with nasal polyps: a network meta-analysis. Allergy Eur J Allergy Clin Immunol. 2022;77:1299–306. https://doi.org/10.1111/all.15205.

Article  Google Scholar 

Oykhman P, Paramo FA, Bousquet J, et al. Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: a systematic review and network meta-analysis. J Allergy Clin Immunol. 2022;149:1286–95. https://doi.org/10.1016/j.jaci.2021.09.009.

Article  CAS  PubMed  Google Scholar 

Sherman RE, Anderson SA, Dal Pan GJ, et al. Real-world evidence — what is it and what can it tell us? N Engl J Med. 2016;375:2293–7. https://doi.org/10.1056/NEJMsb1609216.

Article  PubMed  Google Scholar 

Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58:1–464. https://doi.org/10.4193/Rhin20.600.

Article  PubMed  Google Scholar 

Alobid I, Colás C, Castillo J, et al. Spanish consensus on the management of chronic rhinosinusitis with nasal polyps (POLIposis NAsal/POLINA 2.0). J Investig Allergol Clin Immunol. 2023;33:317–31. https://doi.org/10.18176/jiaci.0910.

Article  CAS  PubMed  Google Scholar 

Fokkens WJ, Viskens A-S, Backer V, et al. EPOS/EUFOREA update on indication and evaluation of biologics in chronic rhinosinusitis with nasal polyps 2023. Rhinology. 2023;61:194–202. https://doi.org/10.4193/Rhin22.489.

Article  CAS  PubMed  Google Scholar 

Bachert C, Mannent L, Naclerio RM, et al. Dupilumab in chronic sinusitis with nasal polyposis, with and without asthma. Allergy Eur J Allergy Clin Immunol. 2015;70:107. https://doi.org/10.1111/all.12715.

Article  Google Scholar 

Boscke R, Bruchhage KL. Real-life data on the effectiveness and safety of dupilumab in adult patients with uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP). Laryngo- Rhino- Otol. 2021;100:S278–9. https://doi.org/10.1055/s-0041-1728626.

Article  Google Scholar 

Cipolla F, La Mantia I. Chronic rinosinusitis with nasal polyps and dupilumab: results after six months of treatment. Allergy Eur J Allergy Clin Immunol. 2023;78:421–2. https://doi.org/10.1111/all.15616.

Article  Google Scholar 

De Prado Gomez L, Khan AH, Peters A, et al. EValuating trEatment RESponses of dupilumab versus omalizumab in type 2 patients: the EVEREST trial. Allergy Eur J Allergy Clin Immunol. 2023;78:616–7. https://doi.org/10.1111/all.15616.

Article  Google Scholar 

Dennis SK, Martin L, Marc D, et al. CRSwNP and dupilumab-experiences after one year of clinical use at a university ENT clinic. Laryngo- Rhino- Otol. 2022;101:S329. https://doi.org/10.1055/s-0042-1747025.

Article  Google Scholar 

Mathias H, Robert B, Marius T, et al. Dupilumab-treatment for uncontrolled CRSwNP: real-life 15-months follow-up data. Laryngo- Rhino- Otol. 2022;101:S332. https://doi.org/10.1055/s-0042-1747000.

Article  Google Scholar 

Schmale I, Poulakis A, Abend A, et al. Real-world outcomes of dupilumab therapy for nasal polyposis in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2023;151:AB218. https://doi.org/10.1016/j.jaci.2022.12.680.

Article  Google Scholar 

Hoffmann AS, Eden J, Jansen F, et al. Efficacy of dupilumab (Dupixent) in the treatment of chronic rhinosinusitis with nasal polyps: first results from Hamburg. Laryngo- Rhino- Otol. 2021;100:S284–5. https://doi.org/10.1055/s-0041-1728858.

Article  Google Scholar 

Sophie HA, Florian J, Benjamin B, et al. Real world data on the effectiveness and safety of dupilumab in adult patients with uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP). Laryngo- Rhino- Otol. 2022;101:S328. https://doi.org/10.1055/s-0042-1747020.

Article  Google Scholar 

Ferreira Gom MP, Ferreira S, Gomes Rosa JP, et al. Chronic rhinosinusitis with nasal polyposis: Portuguese experience with dupilumab in two centers. J Allergy Clin Immunol. 2024;153:AB214. https://doi.org/10.1016/j.jaci.2023.11.691.

Article  Google Scholar 

Juarez C, Eusebio I, Viciana MG, et al. Dupilumab e